Tele-Harm Reduction for Intravenous Drug Use
(T-SHARP Trial)
Trial Summary
Do I need to stop my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators for more details.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators.
What data supports the effectiveness of the Tele-Harm Reduction treatment for intravenous drug use?
What data supports the effectiveness of the Tele-Harm Reduction treatment for intravenous drug use?
Research shows that telehealth approaches, like Tele-Harm Reduction, can improve access to care and support for people who use drugs. For example, telephone counseling has been found to increase comfort, privacy, and access to counselors, which can help overcome barriers to treatment. Additionally, telehealth has been used successfully to initiate treatments for opioid use disorder, suggesting it could be effective for other drug-related interventions.12345
How is the Tele-Harm Reduction treatment different from other treatments for intravenous drug use?
Tele-Harm Reduction is unique because it uses telehealth to provide harm reduction services, making it more accessible for people who inject drugs, especially those living with HIV. This approach helps initiate care quickly and aims to achieve rapid HIV viral suppression, which is not typically the focus of other harm reduction treatments.16789
How is the Tele-Harm Reduction treatment different from other treatments for intravenous drug use?
Tele-Harm Reduction is unique because it uses telehealth to provide harm reduction services, making it more accessible for people who inject drugs, especially those living with HIV. It focuses on rapid initiation of antiretroviral therapy and achieving quick HIV viral suppression, which is not typically the primary focus of other harm reduction interventions.16789
What is the purpose of this trial?
The purpose of this study is to test 2 different methods for offering medications that treat HIV, cure Hepatitis C Virus (HCV) (if applicable) and treat substance use disorder (if desired) to people who inject drugs.
Research Team
Hansel Tookes
Principal Investigator
University of Miami
Eligibility Criteria
This trial is for adults over 18 who use intravenous drugs and are enrolled in specific Substance Use Support Programs in Miami or Tampa. Participants must have HIV with a certain viral load, may also have Hepatitis C, be willing to consent to the study, and not plan to move away within a year. Those already receiving similar interventions or unable to consent are excluded.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive telehealth support and medication for HIV, HCV, and substance use disorder
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Off-site Linkage
- Tele-Harm Reduction
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Miami
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Collaborator